Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news

What Are Laryngeal and Hypopharyngeal Cancers?
Title: What Are Laryngeal and Hypopharyngeal Cancers?Category: Diseases and ConditionsCreated: 3/23/2022 12:00:00 AMLast Editorial Review: 3/23/2022 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 23, 2022 Category: Cancer & Oncology Source Type: news

This 'artificial larynx' prototype aims to give cancer survivors their own voices back
Masaki Takeuchi, a young engineer in Tokyo, Japan, is teaming up with laryngeal cancer survivors to create and test Syrinx -- a machine-learning, hands-free, wearable electrolarynx. (Source: CNN.com - Health)
Source: CNN.com - Health - March 23, 2022 Category: Consumer Health News Source Type: news

New Clinical and Real-World Data Support Use of DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma
ATLANTA, Ga., December 11, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX® (daratumumab)-based regimens may be able to achieve, including a potential survival benefit for DARZALEX® in combination with lenalidomide and dexamethasone (Rd). Updated data from the randomized Phase 2 GRIFFIN study in transplant-eligible patients and real-world evidence in transplant-ineligible patients were presented at the American Society of Hematology (ASH) 2021 Annual Meeting. Data from the GRIFFIN study will also be featured...
Source: Johnson and Johnson - December 11, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Throat cancer symptoms: Key signs of cancer that affect your throat and voice
THROAT CANCER is the name sometimes given to cancers affecting the thyroid, larynx, oesophagus or trachea. What are the symptoms to look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - November 29, 2021 Category: Consumer Health News Source Type: news

Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

How Long Can You Live with Larynx Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 11, 2021 Category: General Medicine Source Type: news

Is Stage 3 Larynx Cancer Curable
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 11, 2021 Category: General Medicine Source Type: news

Coffee protects against liver cancer while alcohol is linked with numerous cancers
Alcohol consumption is a major risk factor for several cancers including head & neck (mouth, pharynx, larynx), oesophageal and bowel cancer - as well as the more widely known links to breast and liver cancer - according to a new study funded by World Cancer Research Fund (WCRF)(1), and published this week in Nature Communications. The study also found increased coffee consumption was associated with a lower risk of developing liver cancer and basal cell carcinoma of the skin. (Source: World Pharma News)
Source: World Pharma News - August 4, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Alcohol caused 740,000 cancer cases globally last year – study
Researchers behind estimate say more needs to be done to raise public awareness of linkAlcohol is estimated to have caused more than 740,000 cancer cases around the world last year, and experts say more needs to be done to highlight the link.There is strong evidence that alcohol consumption can cause various cancers including those of the breast, liver, colon, rectum, oropharynx, larynx and oesophagus. Research suggests that evenlow levels of drinking can increase the risk.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 13, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Alcohol Cancer Medical research Breast cancer Health Science Society Source Type: news

What Does Laryngeal Cancer Feel Like?
Title: What Does Laryngeal Cancer Feel Like?Category: Diseases and ConditionsCreated: 6/29/2021 12:00:00 AMLast Editorial Review: 6/29/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - June 29, 2021 Category: Cancer & Oncology Source Type: news

Janssen Announces Results from Phase 3 MAIA Study Showing Significant Overall Survival Benefits for Treatment with DARZALEX ® (daratumumab) in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant Ineligible
Raritan, N.J., June 12, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced overall survival (OS) results from the Phase 3 MAIA (NCT02252172) study showing the addition of DARZALEX® (daratumumab) to lenalidomide and dexamethasone (D-Rd) resulted in a statistically significant survival benefit over lenalidomide and dexamethasone (Rd) alone in patients with newly diagnosed multiple myeloma (NDMM) who were ineligible for autologous stem cell transplant (ASCT) and were treated to progression.[1] These data were featured in the European Hematology Association (EHA) 2021 Virtual Press Briefing and w...
Source: Johnson and Johnson - June 12, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Highlights Commitment to Advancing Transformative Innovations in Oncology with Scientific Updates from Deep, Diverse Pipeline and Portfolio at ASCO and EHA Virtual Scientific Programs
June 1, 2021 (RARITAN, N.J.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 30 company-sponsored studies, including six oral presentations, will be featured during the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8. Janssen presentations will include new data and updates for both approved and investigational therapeutics that are being studied for the treatment of various solid tumors and blood cancers. Immediately following ASCO, additional data will be featured during the European Hematology Association (EHA) Virtual Congress, June 9-17. A comp...
Source: Johnson and Johnson - June 1, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
Title: Chronic Heartburn Raises Odds for Cancers of Larynx, EsophagusCategory: Health NewsCreated: 2/22/2021 12:00:00 AMLast Editorial Review: 2/23/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 23, 2021 Category: Cancer & Oncology Source Type: news

Chronic Heartburn Raises Odds for Cancers of Larynx, Esophagus
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 23, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, News, Source Type: news